RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Addressing Key Challenges in Drug Safety (Strategic Focus)
Mar 2008 - 34 pages - $3,395
Biosimilars Update
Apr 2011 - $695
Pharmacovigilance and Related Developments 2011-2021
Aug 2011 - 117 pages - $2,350
Drug Combinations: New Rules, New Opportunities
May 2011 - $895
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
May 2011 - 88 pages - $3,500
Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals
Apr 2009 - 136 pages - $2,350
Computer Service Partners, Inc., IT Services - Contracts Review, 2000-2010
Dec 2010 - 21 pages - $500
Risk Evaluation and Mitigation Strategies (REMS)
Aug 2011 - 120 pages - $3,835
Bull AG, IT Services - Contracts Review, 2000-2010
Dec 2010 - 47 pages - $500
CareTech Solutions Inc., IT Services - Contracts Review, 2000-2010
Dec 2010 - 60 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us